NO20006352L - Anvendelse av diazepiner til fremstilling av medisiner for behandling av patologiske tilstander eller sykdommer som involverer en av veksthormon-frigjöringsinhiberingsfaktor- reseptorene - Google Patents
Anvendelse av diazepiner til fremstilling av medisiner for behandling av patologiske tilstander eller sykdommer som involverer en av veksthormon-frigjöringsinhiberingsfaktor- reseptorene Download PDFInfo
- Publication number
- NO20006352L NO20006352L NO20006352A NO20006352A NO20006352L NO 20006352 L NO20006352 L NO 20006352L NO 20006352 A NO20006352 A NO 20006352A NO 20006352 A NO20006352 A NO 20006352A NO 20006352 L NO20006352 L NO 20006352L
- Authority
- NO
- Norway
- Prior art keywords
- diazepines
- treatment
- medicaments
- manufacture
- pathological conditions
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims 2
- 230000001575 pathological effect Effects 0.000 title claims 2
- 101000632994 Homo sapiens Somatostatin Proteins 0.000 title 1
- 102100029563 Somatostatin Human genes 0.000 title 1
- 150000004908 diazepines Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229960000553 somatostatin Drugs 0.000 title 1
- 108700021154 Metallothionein 3 Proteins 0.000 claims 1
- 102100028708 Metallothionein-3 Human genes 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9807509A FR2779652B1 (fr) | 1998-06-15 | 1998-06-15 | Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique |
| PCT/FR1999/001422 WO1999065917A1 (fr) | 1998-06-15 | 1999-06-15 | Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20006352L true NO20006352L (no) | 2000-12-13 |
| NO20006352D0 NO20006352D0 (no) | 2000-12-13 |
Family
ID=9527389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006352A NO20006352D0 (no) | 1998-06-15 | 2000-12-13 | Anvendelse av diazepiner til fremstilling av medisiner for behandling av patologiske tilstander eller sykdommer som involverer en av veksthormon-frigjöringsinhiberingsfaktor- reseptorene |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7015213B1 (ru) |
| EP (1) | EP1087978A1 (ru) |
| JP (1) | JP2002518400A (ru) |
| KR (1) | KR20010052836A (ru) |
| CN (1) | CN100348600C (ru) |
| AR (1) | AR019669A1 (ru) |
| AU (1) | AU758206B2 (ru) |
| CA (1) | CA2335724A1 (ru) |
| FR (1) | FR2779652B1 (ru) |
| HK (1) | HK1039780A1 (ru) |
| HU (1) | HUP0102300A3 (ru) |
| IL (1) | IL139954A0 (ru) |
| MY (1) | MY118652A (ru) |
| NO (1) | NO20006352D0 (ru) |
| NZ (1) | NZ509313A (ru) |
| PL (1) | PL344831A1 (ru) |
| RU (1) | RU2229299C2 (ru) |
| TW (1) | TW513434B (ru) |
| WO (1) | WO1999065917A1 (ru) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001255708A1 (en) * | 2000-04-28 | 2001-11-12 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Synthesis and use of thienotriazolodiazepines |
| WO2002057241A1 (en) * | 2000-12-22 | 2002-07-25 | Bayer Pharmaceuticals Corporation | 8-(AMINOALKOXYMINO)-8H-DIBENZO[a,e]TRIAZOLO[4,5-c]CYCLOHEPTENES AS GROWTH HORMONE SECRETAGOGUES |
| CA2710740C (en) * | 2007-12-28 | 2016-07-19 | Shinji Miyoshi | Thienotriazolodiazepine compound as antitumor agent |
| JP6022442B2 (ja) | 2010-05-14 | 2016-11-09 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | 男性用避妊組成物および使用方法 |
| CN103154246B (zh) | 2010-05-14 | 2015-11-25 | 达那-法伯癌症研究所 | 用于治疗白血病的组合物和方法 |
| PT2571503E (pt) | 2010-05-14 | 2015-04-29 | Dana Farber Cancer Inst Inc | Composições e a sua utilização no tratamento de neoplasia, doença inflamatória e outros distúrbios |
| WO2012075456A1 (en) | 2010-12-02 | 2012-06-07 | Constellation Pharmaceuticals | Bromodomain inhibitors and uses thereof |
| AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| US9422292B2 (en) | 2011-05-04 | 2016-08-23 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| US9328117B2 (en) | 2011-06-17 | 2016-05-03 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| US9624244B2 (en) | 2012-06-06 | 2017-04-18 | Constellation Pharmaceuticals, Inc. | Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof |
| TWI602820B (zh) | 2012-06-06 | 2017-10-21 | 星宿藥物公司 | 溴域抑制劑及其用途 |
| RU2016105108A (ru) | 2013-07-25 | 2017-08-30 | Дана-Фарбер Кэнсер Инститьют, Инк. | Ингибиторы факторов транскрипции и их применение |
| WO2015070020A2 (en) | 2013-11-08 | 2015-05-14 | Dana-Farber Cancer Institute, Inc. | Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors |
| KR20160115953A (ko) | 2014-01-31 | 2016-10-06 | 다나-파버 캔서 인스티튜트 인크. | 디아미노피리미딘 벤젠술폰 유도체 및 그의 용도 |
| JP2017504651A (ja) | 2014-01-31 | 2017-02-09 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | ジアゼパン誘導体の使用 |
| MX2016011160A (es) * | 2014-02-28 | 2017-04-27 | Tensha Therapeutics Inc | Tratamiento de afecciones asociadas con la hiperinsulinemia. |
| CN106687463B (zh) | 2014-06-20 | 2019-04-09 | 星座制药公司 | 一种乙酰胺类化合物的晶型 |
| BR112017002369A2 (pt) | 2014-08-08 | 2017-12-05 | Dana Farber Cancer Inst Inc | derivados de diazepana e usos dos mesmos |
| JP2017525759A (ja) | 2014-08-08 | 2017-09-07 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | ジヒドロプテリジノン誘導体およびその使用 |
| EP3212654B1 (en) | 2014-10-27 | 2020-04-08 | Tensha Therapeutics, Inc. | Bromodomain inhibitors |
| EP3307728A4 (en) | 2015-06-12 | 2019-07-17 | Dana Farber Cancer Institute, Inc. | ASSOCIATION THERAPY USING TRANSCRIPTION INHIBITORS AND KINASE INHIBITORS |
| SG10202007099TA (en) | 2015-09-11 | 2020-08-28 | Dana Farber Cancer Inst Inc | Acetamide thienotriazoldiazepines and uses thereof |
| JP2018526421A (ja) | 2015-09-11 | 2018-09-13 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | シアノチエノトリアゾロジアゼピンおよびこれらの使用 |
| EP3380100A4 (en) | 2015-11-25 | 2019-10-02 | Dana-Farber Cancer Institute, Inc. | BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF |
| AU2018330578B2 (en) * | 2017-09-07 | 2022-11-10 | Eisai R&D Management Co., Ltd. | Pentacyclic compound |
| AR118235A1 (es) | 2019-03-05 | 2021-09-22 | Eisai R&D Man Co Ltd | Heterociclos pentacíclicos |
| KR20210135223A (ko) | 2019-03-05 | 2021-11-12 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 펜타시클릭 화합물의 염 및 이의 결정 |
| CN111533745A (zh) * | 2020-05-20 | 2020-08-14 | 成都药明康德新药开发有限公司 | 叔丁基-3-(氨基甲基)二氢-5h-三唑并二氮杂卓-8(9h)-甲酸基酯制法 |
| KR20230109692A (ko) | 2020-11-16 | 2023-07-20 | 베링거 인겔하임 인터내셔날 게엠베하 | 혈소판 활성화 인자 수용체 길항제로서의 시클로펜타티오펜 카복스아미드 유도체 |
| US11992494B2 (en) | 2021-12-22 | 2024-05-28 | Boehringer Ingelheim International Gmbh | Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI95708C (fi) * | 1988-10-31 | 1996-03-11 | Eisai Co Ltd | Analogiamenetelmä 1,4-diatsepiinijohdannaisen ja sen farmaseuttisesti sopivan suolan valmistamiseksi |
| GB8907256D0 (en) * | 1989-03-31 | 1989-05-17 | Rech Et D Applic Scient Scras | New derivatives of hetrazepine as anti-asthmatic anti-allergic and gastro-intestinal protectors |
| OA09202A (fr) * | 1990-04-02 | 1992-06-30 | Sod Conseils Rech Applic | Procédé de préparation des nouveaux dérivés de la thiéno-triazolo-diazépine. |
| DE4107521A1 (de) * | 1991-03-08 | 1992-09-10 | Boehringer Ingelheim Kg | Neue acylaminosubstituierte hetrazepine |
| US5593988A (en) * | 1991-10-11 | 1997-01-14 | Yoshitomi Pharmaceutical Industries, Ltd. | Therapeutic agent for osteoporosis and diazepine compound |
| JP2001502712A (ja) * | 1996-10-31 | 2001-02-27 | ノボ ノルディスク アクティーゼルスカブ | 束縛されたソマトスタチン・アゴニスト及びアンタゴニスト |
-
1998
- 1998-06-15 FR FR9807509A patent/FR2779652B1/fr not_active Expired - Fee Related
-
1999
- 1999-06-15 AR ARP990102861A patent/AR019669A1/es unknown
- 1999-06-15 NZ NZ509313A patent/NZ509313A/xx unknown
- 1999-06-15 CN CNB998087092A patent/CN100348600C/zh not_active Expired - Fee Related
- 1999-06-15 PL PL99344831A patent/PL344831A1/xx unknown
- 1999-06-15 MY MYPI99002451A patent/MY118652A/en unknown
- 1999-06-15 IL IL13995499A patent/IL139954A0/xx not_active IP Right Cessation
- 1999-06-15 HU HU0102300A patent/HUP0102300A3/hu unknown
- 1999-06-15 RU RU2001101481/15A patent/RU2229299C2/ru not_active IP Right Cessation
- 1999-06-15 CA CA002335724A patent/CA2335724A1/fr not_active Abandoned
- 1999-06-15 US US09/701,893 patent/US7015213B1/en not_active Expired - Fee Related
- 1999-06-15 EP EP99925093A patent/EP1087978A1/fr not_active Withdrawn
- 1999-06-15 KR KR1020007014166A patent/KR20010052836A/ko not_active Application Discontinuation
- 1999-06-15 AU AU41495/99A patent/AU758206B2/en not_active Ceased
- 1999-06-15 JP JP2000554742A patent/JP2002518400A/ja active Pending
- 1999-06-15 WO PCT/FR1999/001422 patent/WO1999065917A1/fr not_active Application Discontinuation
- 1999-07-30 TW TW088109993A patent/TW513434B/zh not_active IP Right Cessation
-
2000
- 2000-12-13 NO NO20006352A patent/NO20006352D0/no not_active Application Discontinuation
-
2002
- 2002-02-22 HK HK02101333.2A patent/HK1039780A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL344831A1 (en) | 2001-11-19 |
| HUP0102300A2 (hu) | 2001-11-28 |
| JP2002518400A (ja) | 2002-06-25 |
| AU758206B2 (en) | 2003-03-20 |
| RU2229299C2 (ru) | 2004-05-27 |
| AU4149599A (en) | 2000-01-05 |
| TW513434B (en) | 2002-12-11 |
| CA2335724A1 (fr) | 1999-12-23 |
| FR2779652B1 (fr) | 2001-06-08 |
| IL139954A0 (en) | 2002-02-10 |
| MY118652A (en) | 2004-12-31 |
| CN100348600C (zh) | 2007-11-14 |
| FR2779652A1 (fr) | 1999-12-17 |
| AR019669A1 (es) | 2002-03-13 |
| CN1309657A (zh) | 2001-08-22 |
| HUP0102300A3 (en) | 2002-10-28 |
| EP1087978A1 (fr) | 2001-04-04 |
| WO1999065917A1 (fr) | 1999-12-23 |
| HK1039780A1 (zh) | 2002-05-10 |
| NO20006352D0 (no) | 2000-12-13 |
| NZ509313A (en) | 2002-11-26 |
| US7015213B1 (en) | 2006-03-21 |
| KR20010052836A (ko) | 2001-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20006352L (no) | Anvendelse av diazepiner til fremstilling av medisiner for behandling av patologiske tilstander eller sykdommer som involverer en av veksthormon-frigjöringsinhiberingsfaktor- reseptorene | |
| HUP0302131A2 (hu) | Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények | |
| EE200100010A (et) | Kinoliini derivaadid, nende kasutamine ravimina, neid sisaldavad farmatseutilised kompositsioonid ning ühendite ja farmatseutiliste kompositsioonide kasutamine patoloogilisest põletikust ja autoimmuunsusest tingitud haiguste ravis | |
| EE200100007A (et) | Kinoliini derivaadid, nende kasutamine ravimina, neid sisaldavad farmatseutilised kompositsioonid ning ühendite ja farmatseutiliste kompositsioonide kasutamine patoloogilisest põletikust ja autoimmuunsusest tingitud haiguste ravis | |
| NO20002113D0 (no) | Nye tricykliske forbindelser og deres anvendelse i medisin, fremgangsmÕte for deres fremstillling og farmasøytiske sammensetninger inneholdende dem | |
| AR005282A1 (es) | Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura. | |
| DE69906518D1 (de) | Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis | |
| HUP0200714A2 (hu) | Gyógyhatású vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| EE200000380A (et) | 11ß-halogeno-7(alfa)-asendatud östratrieenid, neid 11ß-halogeno-7(alfa)-asendatud östratrieene sisaldavate farmatseutiliste preparaatide valmistamise meetodid ja nende kasutamine ravimite valmistamiseks | |
| CA2302396A1 (en) | Allosteric adenosine receptor modulators | |
| HUP0204085A3 (en) | New oxabispidine compounds useful in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them | |
| IL167250A (en) | Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases | |
| NO973243D0 (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av gynekologiske sykdommer | |
| NO973884L (no) | Aminosyrepreparater og anvendelse derav for klinisk ernæring | |
| ATE200422T1 (de) | Verwendung von boswelliasäure und ihren derivaten zur hemmung der normalen und gesteigerten leukozytenelastase- oder plasminaktivität | |
| HUP0301030A3 (en) | New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them | |
| HUP9904317A3 (en) | Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases | |
| NO323466B1 (no) | Nye kinolinyl-piperidin-4-yliden-metyl-benzamidderivater, fremgangsmate til fremstilling derav, anvendelse derav i medikamenter til behandling av smerte, samt farmasoytisk sammensetning som innbefatter slike derivater | |
| TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
| EP0657167A3 (fr) | Application de l'oenothéine B pour obtenir un médicament destiné au traitement des troubles liés à l'hyperandrogénie, les compositions pharmaceutiques le contenant et un procédé de préparation à partir d'Epilobium Parviflorum. | |
| ES2299878T3 (es) | Utilizacion de higos chumbos (opuntia) para la preparacion de un medicamento para el tratamiento de depresiones. | |
| NO973342D0 (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av cerebrale degenerative sykdommer | |
| CA2319542A1 (en) | The treatment of sexual dysfunction in certain patient groups | |
| DE02748548T1 (de) | Calcium-l-threonat zur prävention oder behandlung von knochenfrakturen | |
| IT9019793A0 (it) | Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |